Last reviewed · How we verify

PENG block and cryoablation

University of Minnesota · FDA-approved active Small molecule

PENG block is a regional anesthesia technique that combines a peripheral nerve block with cryoablation to provide prolonged pain relief by freezing nerve tissue.

The University of Minnesota is investigating the use of PENG block and cryoablation for pain management in patients with hip fractures. This Phase 4 trial compares the efficacy and safety of PENG block and cryoablation to the Fascia Iliaca Catheter, aiming to improve postoperative pain control and reduce opioid use.

At a glance

Generic namePENG block and cryoablation
SponsorUniversity of Minnesota
ModalitySmall molecule
Therapeutic areaPain Management / Anesthesia
PhaseFDA-approved

Mechanism of action

PENG (Pectineus Compartment) block targets the obturator and femoral nerves in the pectineus compartment, and when combined with cryoablation (controlled freezing of nerve tissue), it creates a longer-lasting analgesic effect than traditional nerve blocks alone. This combination approach is used perioperatively and for chronic pain management to reduce opioid requirements and improve patient outcomes.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results